Commonly Used FDA Approved Treatments for Metastatic Castrate Resistant Prostate Cancer (mCRPC)
The first line of treatment for advanced prostate cancer is Androgen (male hormone) Deprivation Therapy or ADT. Once the PSA progresses (climbs) while still on ADT and with testosterone levels
Cleveland Clinic Identifies Genetic Mutation in a Deadly form of Prostate Cancer
Dr. Nima Sharifi from the Cleveland Clinic’s Lerner Research Institute has claimed to have identified a genetic mutation in one of the deadliest forms of prostate cancer. His finding, published online today in the journal [...]
Prostate Cancer Awareness Events in September
September is Prostate Cancer Awareness month and many organizations that are involved with education and support of men (and their families) who have prostate cancer are scheduled to have programs during the month. There are [...]
Canada Gets the Nod for the Use of Xtandi
Some good news for my neighbors immediately to my north. Enzalutamide (Xtandi) has received Health Canada's approval for the treatment of metastatic castration-resistand advanced prostate cancer in the post chemotherapy phase. This means that any [...]
Evidence Against Step Therapy Being Good for Prostate Cancer Care
On August 13, 2013 I wrote an important post about the terrible practice beginning to rear its head called step therapy. Step therapy is the practice of insurance companies requiring less expensive drugs be prescribed [...]
Xofigo – Designed to be Used with the Best Standard of Care Treatments
Most of the newly approved drugs and treatments for men with advanced prostate cancer are designed and approved to be used independently of other advanced prostate cancer treatments, other than with the continuation of standard [...]